Label: NYSTATIN- nystatin ointment
- NDC Code(s): 45802-048-11, 45802-048-35
- Packager: Perrigo New York Inc
- Category: HUMAN PRESCRIPTION DRUG LABEL
Updated November 1, 2018
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- SPL UNCLASSIFIED SECTION
For Dermatologic Use Only
Not For Ophthalmic Use
Nystatin Ointment USP for topical use only, contains 100,000 USP Nystatin units per gram, in an ointment base of light mineral oil and white petrolatum. The structural formula is as follows:
Molecular Weight 926.13
Molecular Formula C47H75NO17Close
- CLINICAL PHARMACOLOGY
Nystatin is an antifungal antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It probably acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is a polyene antibiotic that is obtained from Streptomyces noursei, and is the first well tolerated antifungal antibiotic of dependable efficacy for the treatment of cutaneous, oral and intestinal infections caused by Candida [Monilia]albicans and other Candida species. It exhibits no appreciable activity against bacteria.
Nystatin Ointment USP provides specific therapy for all localized forms of candidiasis. Symptomatic relief is rapid, often occurring within 24 to 72 hours after the initiation of treatment. Cure is effected both clinically and mycologically in most cases of localized candidiasis.Close
- INDICATIONS AND USAGE
Nystatin Ointment USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida [Monilia]albicans and other Candida species.Close
Nystatin Ointment USP is contraindicated in patients with a history of hypersensitivity to any of its components.Close
Should a reaction of hypersensitivity occur, the drug should be immediately withdrawn and appropriate measures taken.
This preparation is not for ophthalmic use.Close
- ADVERSE REACTIONS
Nystatin Ointment USP is virtually non-toxic and nonsensitizing and is well tolerated by all age groups including debilitated infants, even on prolonged administration. If irritation on topical application should occur, discontinue medication.Close
- DOSAGE AND ADMINISTRATION
Nystatin Ointment USP should be applied liberally to affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving intertriginous areas; very moist lesions, however, are best treated with nystatin topical powder.
This preparation does not stain skin or mucous membranes and provides a simple, convenient means of treatment.Close
- HOW SUPPLIED
Nystatin Ointment USP (100,000 USP Nystatin Units per gram) is a yellow ointment available as follows:
15 g tube (NDC 45802-048-35)
30 g tube (NDC 45802-048-11)
Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].
Manufactured By Perrigo
Bronx, NY 10457
Allegan, MI 49010 • www.perrigo.com
: 2K800 RC JX1
- Principal Display Panel
Nystatin Ointment USP
(100,000 USP Nystatin Units)
NET WT 15 g
The following image is a placeholder representing the product identifier that is either affixed or imprinted on the drug package label during the packaging operation.Close
- INGREDIENTS AND APPEARANCE
Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:45802-048 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NYSTATIN (UNII: BDF1O1C72E) (NYSTATIN - UNII:BDF1O1C72E) NYSTATIN 100000 [USP'U] in 1 g Inactive Ingredients Ingredient Name Strength LIGHT MINERAL OIL (UNII: N6K5787QVP) PETROLATUM (UNII: 4T6H12BN9U) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:45802-048-35 1 in 1 CARTON 09/15/2006 1 15 g in 1 TUBE; Type 0: Not a Combination Product 2 NDC:45802-048-11 1 in 1 CARTON 11/08/2006 2 30 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA062472 09/15/2006 Labeler - Perrigo New York Inc (078846912)